Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Offering

  2.3.2 Market Size By Application

  2.3.3 Market Size By Component

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO's Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter's) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1. Compute & Infrastructure Providers

  3.4.2. AI Platform & Model Developers

  3.4.3. Pharmaceutical, Biotech & Diagnostic Sponsors

  3.4.4. CRO, CDMO & Academic End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Technology & Platform Metrics

  4.1.1 Foundation Model Development Activity

  4.1.2 End-to-End vs. Point Solution Adoption

 4.2 Regulatory & Governance Pathways

  4.2.1 AI-Specific Review Pathway Development

  4.2.2 EU AI Act Compliance Activity

  4.2.3 Data Privacy & Governance Risk

  4.2.4 Unsanctioned AI Use Trends

 4.3 Investment & Deal Statistics

  4.3.1 Co-Innovation Lab & Infrastructure Deals

  4.3.2 Milestone & Equity-Linked Partnership Structures

  4.3.3 Sovereign & Government-Backed Capital Flows

  4.3.4 Cross-Border Licensing Deal Volume

 4.4 Demand Context

  4.4.1 Pharmaceutical R&D Budget Allocation

  4.4.2 Biotechnology AI-Native Platform Adoption

  4.4.3 Clinical vs. Non-Clinical Application Mix

  4.4.4 CRO & CDMO Service Demand

 4.5 Commercial Development Outcomes

  4.5.1 New Platform & Model Launches

  4.5.2 Strategic Partnership & Collaboration Activity

  4.5.3 Regional Capacity-Building Investment

  4.5.4 Mergers, Acquisitions & Divestitures

5. AI in Life Science Market Segmental Analysis, By Offering

 5.1 Introduction

 5.2 End-to-End Solutions

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Niche and Point Solutions

 5.4 AI Technology

 5.5 Services

6. AI in Life Science Market Segmental Analysis, By Application

 6.1 Introduction

 6.2 Clinical

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Non-Clinical

7. AI in Life Science Market Segmental Analysis, By Component

 7.1 Introduction

 7.2 Software

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Services

8. AI in Life Science Market Segmental Analysis, By End User

 8.1 Introduction

 8.2 CRO & CDMO

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Pharmaceutical Companies

 8.4 Biotechnology Companies

 8.5 Diagnostic Companies

 8.6 Academic & Government Laboratories

9. AI in Life Science Market Segmental Analysis, By Region

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 AI in Life Science Market Size & Forecast, By Offering, 2022–2035

  9.2.3 AI in Life Science Market Size & Forecast, By Application, 2022–2035

  9.2.4 AI in Life Science Market Size & Forecast, By Component, 2022–2035

  9.2.5 AI in Life Science Market Size & Forecast, By End User, 2022–2035

  9.2.6 AI in Life Science Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 US

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 AI in Life Science Market Size & Forecast, By Offering, 2022–2035

  9.3.3 AI in Life Science Market Size & Forecast, By Application, 2022–2035

  9.3.4 AI in Life Science Market Size & Forecast, By Component, 2022–2035

  9.3.5 AI in Life Science Market Size & Forecast, By End User, 2022–2035

  9.3.6 AI in Life Science Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 France

   9.3.6.3 UK

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Poland

   9.3.6.7 Russia

   9.3.6.8 Rest of Europe

 9.4 Asia Pacific

  9.4.1 Key Trends

  9.4.2 AI in Life Science Market Size & Forecast, By Offering, 2022–2035

  9.4.3 AI in Life Science Market Size & Forecast, By Application, 2022–2035

  9.4.4 AI in Life Science Market Size & Forecast, By Component, 2022–2035

  9.4.5 AI in Life Science Market Size & Forecast, By End User, 2022–2035

  9.4.6 AI in Life Science Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 AI in Life Science Market Size & Forecast, By Offering, 2022–2035

  9.5.3 AI in Life Science Market Size & Forecast, By Application, 2022–2035

  9.5.4 AI in Life Science Market Size & Forecast, By Component, 2022–2035

  9.5.5 AI in Life Science Market Size & Forecast, By End User, 2022–2035

  9.5.6 AI in Life Science Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 AI in Life Science Market Size & Forecast, By Offering, 2022–2035

  9.6.3 AI in Life Science Market Size & Forecast, By Application, 2022–2035

  9.6.4 AI in Life Science Market Size & Forecast, By Component, 2022–2035

  9.6.5 AI in Life Science Market Size & Forecast, By End User, 2022–2035

  9.6.6 AI in Life Science Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 NVIDIA Corporation

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 Alphabet Inc. (Google Cloud / Isomorphic Labs)

  10.6.3 Tempus AI, Inc.

  10.6.4 Dassault Systèmes

  10.6.5 Recursion Pharmaceuticals, Inc.

  10.6.6 Schrödinger, Inc.

  10.6.7 Microsoft Corporation

  10.6.8 Insilico Medicine

  10.6.9 Owkin, Inc.

  10.6.10 PathAI, Inc.

  10.6.11 Aidoc Medical Ltd.

  10.6.12 Qure.ai Technologies

  10.6.13 SOPHiA GENETICS SA

  10.6.14 SandboxAQ

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures